Structural variation in human apolipoprotein E3 and E4: secondary structure, tertiary structure, and size...

Apolipoprotein E (apoE) plays a key role in lipid metabolism and brain function. Two major isoforms, apoE3 and apoE4, differ by a single amino acid at position 112. ApoE4 is strongly linked to atherosclerosis and Alzheimer's disease (AD), but the structural basis for this association remains unclear. Prior research has shown that apoE4 accumulates in AD brain lesions, yet detailed structural differences between apoE isoforms are limited. This gap motivated a closer examination of how structural variations in apoE3 and apoE4 might influence their behavior. No prior work had resolved how domain interactions affect apoE aggregation. Understanding these differences could clarify why apoE4 is more prone to misfolding and aggregation. This uncertainty drove the need to investigate apoE3 and apoE4 structural properties in detail. The study aimed to address this knowledge gap by comparing their structural characteristics.

The study aimed to compare structural features of apoE3 and apoE4 isoforms to understand their differing roles in disease. Specifically, the researchers focused on how structural variations in these proteins might contribute to apoE4's greater tendency to aggregate. The motivation stemmed from the known association between apoE4 and AD pathology. By analyzing truncated and full-length forms, the team sought to identify structural differences that could explain functional disparities. The study also aimed to determine how domain interactions influence apoE behavior. The goal was to clarify whether apoE4's structural properties make it more likely to misfold or aggregate. This approach could help explain why apoE4 is more frequently found in AD brain lesions. The findings may suggest new insights into apoE's role in disease progression.

The researchers prepared full-length and truncated forms of apoE3 and apoE4 proteins. They used analytical ultracentrifugation to examine sedimentation velocity and size distribution. Circular dichroism (CD) spectroscopy was employed to assess secondary structure differences. Fluorescence studies provided information on hydrophobic residue exposure. Truncated forms included N-terminal (1-191) and C-terminal (192-271) regions of apoE. The team compared monomer and tetramer distributions in each isoform. They also analyzed how the C-terminal domain affects oligomerization. The methods focused on structural and aggregation properties of apoE isoforms.

ApoE3(72-299) showed a sedimentation coefficient of 5.9, indicating a major species. ApoE4(72-299) displayed a broader and more complex size distribution. Both apoE3 and apoE4 N-terminal domains existed as monomers with some tetramer. The C-terminal domain increased oligomerization and aggregation in both isoforms. CD and fluorescence studies showed apoE4 had a more alpha-helical structure. ApoE4 also revealed greater hydrophobic residue exposure compared to apoE3. The C-terminal domain aided self-association without isoform preference. These findings suggest structural differences influence apoE4's aggregation behavior.

The structural differences between apoE3 and apoE4 may explain apoE4's greater aggregation tendency. The C-terminal domain promotes self-association in both isoforms. ApoE4's alpha-helical structure and hydrophobic exposure may contribute to its pathogenic role. These findings align with the known association between apoE4 and AD pathology. The study highlights how structural variations affect apoE function. The results may suggest why apoE4 accumulates in AD brain lesions. The findings support the idea that apoE4's structure increases its aggregation potential. These conclusions are based on the observed structural and aggregation differences.